イヌおよびネコの麻酔におけるキシラジンの臨床応用に関する検討

書誌事項

タイトル別名
  • CLINICAL USE OF XYLAZINE IN ANESTHESIA OF DOG AND CAT

この論文をさがす

説明

In the present paper, the possibility of clinical use of Xylazine in the anesthesia of dog and cat was discussed based upon experiments with overdose of Xylazine and upon clinical use of Xylazine-Ketamine hydrochloride combination and of Xylazine-Pentobarbital sodium combination in dogs and cats.<BR>Administration of 9 mg/kg (about three times of usually recommended dose as anesthetics) of Xylazine through various routes was proved at least not to be fatal as far as clinical manifestations are concerned, as all animals could tolerate this dosage without any serious troubles.<BR>Since, even with quite high dosage of Xylazine as high as 9 mg/kg, deep anesthesia could not be obtained, Xylazine was used in combination with Ketamine hydrochloride and with Pentobarbital sodium. In both these combinations, more satisfactory anesthesia was obtained, not only with extensively low dosage of Ketamine hydrochloride or of Pentobarbital sodium, but with less undesirable reactions, characteristic in these two anesthetic agents.<BR>Being specific with these combined anesthesia, was that the effective post-anesthetic sedation was retained for rather long period, even after fairly rapid disappearance of anesthetic effects.

収録刊行物

  • 獣医麻酔

    獣医麻酔 7 19-30, 1976

    獣医麻酔外科学会

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

  • CRID
    1390001204719647488
  • NII論文ID
    130004246952
  • DOI
    10.2327/jvas1970.7.19
  • ISSN
    21852987
    02852209
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
    • Crossref
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ